Company: UHS
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0000950170-25-049925
Chunk: 55

Company: UNIVERSAL HEALTH SERVICES INC
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 55
---
 |    20,521 |     | $     |  4,173,981 |
| Executive Vice President and | 2023 |        |   697,527 |     |       |         — |     |     |            | 1,033,791 |     |            | 1,033,818 |     |                  | 1,224,160 |     |               | 40,015 |     |                  |    20,293 |     |       |  4,049,604 |
| President, Behavioral Health | 2022 |        |   666,922 |     |       |         — |     |     |            |   994,015 |     |            |   993,990 |     |                  |         — |     |               | 37,402 |     |                  |    19,216 |     |       |  2,711,545 |

In March, 2024, our CEO and other NEOs each received their annual target stock-based compensation awards in the form of performance-based restricted stock units and time-based restricted stock units. The March, 2024 values represent 100% of the target, with a grant date value of $180.77 per unit. The performance-based restricted stock units for our CEO and other NEOs will be based upon achievement of a pre-established specified range of target levels based on the three-year growth in our earnings before interest, taxes, depreciation and amortization, and the impacts of other income/expenses and net income attributable to noncontrolling interests. The time-based restricted stock units granted to our CEO and other NEOs are scheduled to vest in four equal installments on the first, second, third and fourth anniversaries of the grant date.

In March, 2023, our CEO and other NEOs with the exception of Mr. Edward H. Sim, each received 50% of their annual target stock-based compensation awards in the form of options to purchase shares of our Class B Common Stock at the grant date market value. Amounts in 2023 represent the aggregate fair value of options granted at the market price on the date of grant (grant date fair value of $41.47). In connection with Mr. Sim’s commencement of employment in December, 2022, he was awarded options to purchase shares of our Class B Common Stock in January, 2023, at the grant date market value. Mr. Sim’s amount in 2023 represents